Official Title
The Effect of COVID-19 on the Glycemic Control in Patients With Diabetes Mellitus
Brief Summary

The study aimed to evaluate the effect of SARS-COV-2 infection on metabolic status in patients with diabetes mellitus. Patients' HbA1c levels before and after SARS-COV-2 infection will be evaluated.

Detailed Description

In this time pediods, all patients with RT-PCR positive for SARS-COV-2 will be analysed for
the presence of diabetes mellitus. Previous HbA1c levels will be obtained from hospital
records. In these patients, previous A1c levels and A1c levels 3 months after the SARS-COV-2
infection will be compared.

Unknown status
Diabetes Mellitus
COVID19
Eligibility Criteria

Inclusion Criteria:

- All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled.

Exclusion Criteria:

- The absence of diabetes mellitus RT-PCR- negative for SARS-COV-2 Non-hospitalised
patients

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 80 Years
Countries
Turkey
Locations

Usak University Training and Research Hospital
Usak, Turkey

Investigator: Cevdet Duran
Contact: 05334298585

Contacts

Cevdet Duran
02762212121
drcduran@gmail.com

Cevdet Duran, Prof, Principal Investigator
Uşak University

Uşak University
NCT Number
MeSH Terms
COVID-19
Diabetes Mellitus